10/23
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Displaying 161 - 170 of 397
Penn In the News
U.S. nursing home population shrank roughly 10% this year
Rachel Werner of the Perelman School of Medicine and Leonard Davis Institute said Medicare’s method of reporting nursing home deaths lumps together several time periods. “It doesn’t give us a full picture of the impact of the pandemic,” she said.
Penn In the News
Should you tap retirement funds in a crisis? Increasingly, people say yes
Research by Olivia Mitchell of the Wharton School found that approximately 10% of people who borrow from their 401(k) plans default on the loans.
Penn In the News
Novartis inks deal to make experimental coronavirus vaccines
The pharmaceutical company Novartis has agreed to manufacture a gene-based coronavirus vaccine that Penn helped develop.
Penn In the News
How architects are already planning the future of offices
Marion Weiss of the Stuart Weitzman School of Design spoke about the future of office architecture. “Employers may have fewer people on premises at any one time, but they may need more space per person,” she said.
Penn In the News
Coronavirus revives debate over drug pricing
Patricia Danzon of the Wharton school said that while the private market does incentivize pharmaceutical innovation, “the real question is whether everything that comes out is worth the price we end up paying for it.”
Penn In the News
One idea for speeding a coronavirus vaccine: Deliberately infecting people
Stanley Plotkin of the Perelman School of Medicine weighed in on proposals to use a human challenge trial to fast-track a coronavirus vaccine. “If problems don’t arise along the way, I think it would be reasonable to hope that one could do a human challenge trial in about four months,” he said.
Penn In the News
Coronavirus pushes colleges to the breaking point, forcing ‘hard choices’ about education
In his book “The College Stress Test,” Robert Zemsky of the Graduate School of Education predicted that 10% of private, liberal arts colleges in the U.S. were likely to close within the next five years. Now, with the pandemic’s damaging effects on school finances, his prediction has changed to 200 schools in the next year alone.
Penn In the News
Thousands fighting coronavirus take antimalaria drugs amid uncertainty they help
Benjamin Abella of the Perelman School of Medicine spoke about a study he’s leading to test the efficacy of hydroxychloroquine. “Health care workers are under a lot of stress throughout this whole pandemic, and anything we can do to help lower their risk, because their exposure is pretty much continuous, they’re greatly interested in,” he said.
Penn In the News
Hundreds receive plasma from recovered coronavirus patients in national study
Holly Fernandez Lynch of the Perelman School of Medicine said it’s worth studying the results of experimental therapies for treating COVID-19. “If we keep acting like we can’t study the interventions, then we will be in the same position next time and still not know how to effectively treat people,” she said.
Penn In the News
How to address medical issues unrelated to coronavirus
Joshua Dunaief of the Perelman School of Medicine said patients with macular degeneration shouldn’t postpone injections during the coronavirus pandemic.